Skip to main content

Table 1 Characteristic of 99 advanced serous epithelial ovarian carcinoma patients

From: WT1 gene expression as a prognostic marker in advanced serous epithelial ovarian carcinoma: an immunohistochemical study

Characteristic Number of cases(%)
1. Age (years)  
   ≤ 20 2 (2.0)
   20–30 3 (3.0)
   31–40 3 (3.0)
   41–50 25 (25.3)
   51–60 36 (36.4)
   61–70 23 (23.2)
   71–80 7 (7.1)
2. Parity  
   0 21 (21.2)
   1 11 (11.1)
   2 16 (16.2)
   3 10 (10.1)
   4 12 (12.1)
   5 10 (10.1)
   ≥6 19 (19.2)
3. Chief complain  
   Abdominal distension 54 (54.5)
   Pelvic mass 33 (33.3)
   Bleeding per vagina 4 (4.0)
   Weight loss 1 (1.0)
   Pelvic pain 7 (7.1)
4. FIGO Staging  
   III 85 (85.9)
   IV 14 (14.1)
5. Histologic grade  
   1 60 (60.6)
   2 24 (24.2)
   3 15 (15.2)
6. Residual tumor (cm)  
   None 8 (8.1)
   >0–≤1 4 (4.0)
   >1–≤2 50 (50.5)
   >2 13 (13.2)
   No data 24 (24.2)
7. Percent staining  
   0 49 (49.5)
   1–25 13 (13.1)
   26–50 16 (16.2)
   51–75 12 (12.1)
   ≥76 9 (9.1)
8. Intensity  
   0 (no staining) 49 (49.5)
   1+ 29 (29.3)
   2+ 19 (19.2)
   3+ 2 (2.0)
9. Chemotherapy response  
   Complete 62 (62.6)
   Partial 8 (8.1)
   Stable 8 (8.1)
   Progressive 2 (21.2)
10. Recurrence  
   Yes 54 (77.1)
   No 16 (22.9)
11. Status at last follow-up  
   DWD 69 (69.7)
   DWID 4 (4.0)
   AWD 3 (3.0)
   ANED 7 (7.1)
   Loss follow-up 16 (16.2)
  1. DWD = death of disease, DWND = death with intercurrent disease, AWD = alive with Disease, ANED = alive with no evidence of disease